The transgene-inserted replication-deficit adenovirus vector is effectively used in in vivo gene therapy for peripheral vascular disease and heart disease, including myocardial ischemia, by a single intra-femoral artery or intracoronary injection directly conducted deeply in the lumen of the one or both femoral or coronary arteries (or graft vessels) in an amount sufficient for transfecting cells in a desired region.

 
Web www.patentalert.com

< Pharmaceutical composition containing an active agent in an amino acid copolymer structure

< Coccidiosis poultry vaccine

> Method of sensitizing tumor cells with adenovirus E1A

> Enteric-coated chromium polynicotinate compositions and uses thereof

~ 00205